Navigation Links
Strong Endorsements cited for MedQIA - Imaging CRO's Novel Bone Scan Scoring System at the ASCO 2012 Annual Meeting
Date:7/3/2012

LOS ANGELES, July 3, 2012 /PRNewswire/ -- MedQIA has developed a bone scan analysis package within our 510 (k) – cleared Imaging Biomarker Information System (IBIS). It includes a new automated technique for detecting lesions on bone scans that involves intensity normalization, thresholding, and connected-component analysis. The system calculates quantitative metrics for assessing disease burden and treatment response including total Bone Scan Lesion Area (BSLA), Bone Scan Lesion Intensity (BSLI), and Bone Scan Lesion Count (BSLC).1) During the breakout Oral Session for Prostate Cancer,  Karim Fizazi, MD, Ph.D., of the Institute Gustavo Roussy stated the following: "I would like to emphasize that we now have a new computer assisted detection system available for response in bone scan and I think this is a very important landmark for research in prostate cancer, because it is so difficult to measure response and progression in that disease."2) During the Poster Discussion Session for Genitourinary (Prostate ) Cancer, Ulka Vaishampayan, MD,  stated:"This methodology should be encouraged for future evaluation of novel agents since it lets you keep the efficacy without compromising and continuing to reduce toxicities."This automated system allows for reproducible quantification of metastases in bone scans and reliable interpatient and intrapatient comparison. It has been established as an objective measurement of treatment effects. Trials are ongoing that include validation against other clinically relevant outcome measures.

About MedQIA

MedQIA is a full service Imaging CRO that specializes in Computer Vision systems for automated image analysis and measurement. Computer-calculated imaging biomarkers are more accurate, sensitive, and reproducible than manual human measurements. This results in shorter trials with fewer subjects and enables adaptive study designs. What sets us apart is our ability to develop and validate novel imaging biomarkers for use in global, regulated clinical trials.

MedQIA provides a full range of core laboratory services and handles all aspects of your clinical trial from planning to completion.

We offer our services worldwide with regional offices in the US, Australasia and Europe.

For more information please visit our website at www.medqia.com

Contact Information: Juliette Bridges, MS, MBA – Business Development Manager: jbridges@medqia.com
-888-963-3742


'/>"/>
SOURCE MedQIA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Need for Reduced Healthcare Outlays Creates Strong Growth Potential for Medical Imaging Services, Says Frost & Sullivan
2. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
3. China Health Resource Reports on Record Year-End 2011 Results Continuing Strong in 2012
4. Strong Booking Levels For Informex 2013
5. GHX Reveals Roadmap to Stronger Healthcare Community at GHX Healthcare Supply Chain Summit
6. Stereotaxis Epoch™ Solutions Momentum Drives Strong Presence at the Heart Rhythm Society (HRS) Annual Meeting
7. GP Strategies Reports Strong First Quarter 2012 EPS of $0.23
8. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
9. Frost & Sullivan Recognizes Siemens Healthcares CT Imaging Solution for the Value it Offers Both Service Providers and Patients
10. Global Imaging Agents Industry
11. Medical Imaging Information Systems Market to 2017 - Replacement of Legacy Systems and Advances in Software Present Growth Opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 2016  Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) today ... ended December 31, 2015, the Company achieved revenue of $8,195,839, ... same quarter in fiscal 2015. --> ... fiscal year 2016 was $2,068,635, or $.03 per share, up ... share, in the Q2 of fiscal year 2015. Gross margin ...
(Date:2/8/2016)... http://www.researchandmarkets.com/research/bcrl3s/labelfree ) ... "Label-Free Detection Market by Technology, Products, Applications ... to their offering. --> http://www.researchandmarkets.com/research/bcrl3s/labelfree ... "Label-Free Detection Market by Technology, Products, ... report to their offering. --> ...
(Date:2/8/2016)... 2016  HemaFlo Therapeutics, Inc. announced today that the United ... Number 9,119,880 covering the use of NephroFlow to treat acute ... HemaFlo,s founder, said, "We are pleased to secure our rights ... Peterson , PhD, HemaFlo,s founder, said, "We are pleased to ... --> Dale Peterson , PhD, HemaFlo,s founder, said, ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... 08, 2016 , ... Brenntag Specialties, Inc.(BSI) , is ... & Beverage and Dietary Supplement market segments across the western ... geographies east of the Rocky Mountains since 2012. Consistent performance in business ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Valentine’s Season is famous for gift giving with flowers, ... that they are loved. This year, for more than 5.6 million Americans suffering with ... won't be enough to remind them of the lives they’ve led and the people they’ve ...
(Date:2/8/2016)... ... , ... If you are feeling that your clothes are a tad snug, ... the Center for Disease Control and Prevention (CDC), 34.9% of U.S. adult women are ... cancer, some of the leading causes of preventable death. February is heart health ...
(Date:2/8/2016)... Indianapolis, IN (PRWEB) , ... February 08, 2016 ... ... serving the Indianapolis, IN metro area, has selected the latest beneficiary of their ... nonprofit organization dedicated to preventing bullying in area schools. Donations are now being ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... executive networking and relationship-marketing firm, announced today that nominations will be accepted ... Executive® (ISE®) West Awards. , Awards include the Information Security Executive® ...
Breaking Medicine News(10 mins):